Skip to Content
MilliporeSigma
  • Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodies.

Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodies.

The Journal of biological chemistry (2014-09-23)
Francesco Pisani, Maria Grazia Mola, Laura Simone, Stefania Rosito, Domenico Alberga, Giuseppe Felice Mangiatordi, Gianluca Lattanzi, Orazio Nicolotti, Antonio Frigeri, Maria Svelto, Grazia Paola Nicchia
ABSTRACT

Neuromyelitis optica (NMO) is characterized by the presence of pathogenic autoantibodies (NMO-IgGs) against supra-molecular assemblies of aquaporin-4 (AQP4), known as orthogonal array of particles (OAPs). NMO-IgGs have a polyclonal origin and recognize different conformational epitopes involving extracellular AQP4 loops A, C, and E. Here we hypothesize a pivotal role for AQP4 transmembrane regions (TMs) in epitope assembly. On the basis of multialignment analysis, mutagenesis, NMO-IgG binding, and cytotoxicity assay, we have disclosed the key role of aspartate 69 (Asp(69)) of TM2 for NMO-IgG epitope assembly. Mutation of Asp(69) to histidine severely impairs NMO-IgG binding for 85.7% of the NMO patient sera analyzed here. Although Blue Native-PAGE, total internal reflection fluorescence microscopy, and water transport assays indicate that the OAP Asp(69) mutant is similar in structure and function to the wild type, molecular dynamic simulations have revealed that the D(69)H mutation has the effect of altering the structural rearrangements of extracellular loop A. In conclusion, Asp(69) is crucial for the spatial control of loop A, the particular molecular conformation of which enables the assembly of NMO-IgG epitopes. These findings provide additional clues for new strategies for NMO treatment and a wealth of information to better approach NMO pathogenesis.